Symptomology following mRNA vaccination against SARS-CoV-2

• Published in: Preventive medicine Vol. 153; p. 106860
• Main Authors: Ebinger, Joseph E., Lan, Roy, Sun, Nancy, Wu, Min, Joung, Sandy, Botwin, Gregory J., Botting, Patrick, Al-Amili, Daniah, Aronow, Harriet, Beekley, James, Coleman, Bernice, Contreras, Sandra, Cozen, Wendy, Davis, Jennifer, Debbas, Philip, Diaz, Jacqueline, Driver, Matthew, Fert-Bober, Justyna, Gu, Quanquan, Heath, Mallory, Herrera, Ergueen, Hoang, Amy, Hussain, Shehnaz K., Huynh, Carissa, Kim, Linda, Kittleson, Michelle, Liu, Yunxian, Lloyd, John, Luong, Eric, Malladi, Bhavya, Merchant, Akil, Merin, Noah, Mujukian, Angela, Nguyen, Nathalie, Nguyen, Trevor-Trung, Pozdnyakova, Valeriya, Rashid, Mohamad, Raedschelders, Koen, Reckamp, Karen L., Rhoades, Kylie, Sternbach, Sarah, Vallejo, Rocío, White, Shane, Tompkins, Rose, Wong, Melissa, Arditi, Moshe, Figueiredo, Jane C., Van Eyk, Jennifer E., Miles, Peggy B., Chavira, Cynthia, Shane, Rita, Sobhani, Kimia, Melmed, Gil Y., McGovern, Dermot P.B., Braun, Jonathan G., Cheng, Susan, Minissian, Margo B.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2021; The Authors. Published by Elsevier Inc
• Subjects: COVID-19; COVID-19 Vaccines; Female; Humans; RNA, Messenger; SARS-CoV-2; Vaccination; Vaccine-associated symptoms; Vaccine-associated symptoms; SARS-CoV-2; Vaccination

Despite demonstrated efficacy of vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease-2019 (COVID-19), widespread hesitancy to vaccination persists. Improved knowledge regarding frequency, severity, and duration of vaccine-associat...